Chinese package insert for Nusinersen Sodium Injection 5 ml:12 mg covering indications, dosing schedule, intrathecal administration and safety information.
This is the Chinese package insert (说明书) for Nusinersen Sodium Injection, a colorless clear liquid supplied as 5 ml:12 mg (calculated as nusinersen). The insert lists the drug name, active substance, excipients, description, indication for the treatment of 5q spinal muscular atrophy, and strength. Revision dates shown on the first page run from 22 February 2019 to 30 March 2023.
The body of the text sets out the dosing schedule (12 mg per dose on days 0, 14, 28 and 63 as loading doses, then a maintenance dose every 4 months), a table for delayed or missed doses, and instructions for preparing and giving the drug by lumbar puncture intrathecal injection. It also covers use in patients with kidney or liver impairment, adverse reactions from clinical studies and post-marketing experience, immunogenicity, contraindications and precautions such as thrombocytopenia and coagulation abnormalities. This manual is written in Chinese.
| Strength | 5 ml:12 mg (calculated as nusinersen) |
|---|---|
| Description | Colorless clear liquid |
| Molecular formula | C234H323N61O128P17S17Na17 |
| Molecular weight | 7501.0 |
| Recommended dose | 12 mg (5 ml) per dose |
| Route of administration | Intrathecal injection by lumbar puncture |
It is indicated for the treatment of 5q spinal muscular atrophy.
The recommended dose is 12 mg (5 ml); four loading doses are given on days 0, 14, 28 and 63, followed by a maintenance dose every 4 months.
It is given intrathecally by lumbar puncture by a healthcare professional experienced in lumbar puncture, as a bolus over 1 to 3 minutes.
It is contraindicated in patients allergic to the active substance or to any of the excipients.